Elanco Animal Health Inc (ELAN) stock
ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$25.85−0.56 (-2.12%)
Close on Nov 17, 2026Market cap $12.92BP/E –Yield –
Elanco Animal Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Elanco Animal Health's profit margin for the twelve months ending Jun 30, 2026 was -4.0%. For fiscal 2025 it was -4.9%, against 7.6% the year before. The highest annual figure on record is 7.6% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -4.9% | −12.5 |
| FY2024 | Dec 31, 2024 | 7.6% | +35.5 |
| FY2023 | Dec 31, 2023 | -27.9% | −26.1 |
| FY2022 | Dec 31, 2022 | -1.8% | +8.4 |
| FY2021 | Dec 31, 2021 | -10.1% | +7.4 |
| FY2020 | Dec 31, 2020 | -17.5% | −19.8 |
| FY2019 | Dec 31, 2019 | 2.2% | −0.6 |
| FY2018 | Dec 31, 2018 | 2.8% | +13.6 |
| FY2017 | Dec 31, 2017 | -10.8% | −9.1 |
| FY2016 | Dec 31, 2016 | -1.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 3.9% | +3.1 |
| Q1 FY2026 | Mar 31, 2026 | 4.2% | −1.5 |
| Q4 FY2025 | Dec 31, 2025 | -24.1% | −23.3 |
| Q3 FY2025 | Sep 30, 2025 | -3.0% | −38.3 |
| Q2 FY2025 | Jun 30, 2025 | 0.9% | +5.1 |
| Q1 FY2025 | Mar 31, 2025 | 5.6% | +3.0 |
| Q4 FY2024 | Dec 31, 2024 | -0.8% | +12.8 |
| Q3 FY2024 | Sep 30, 2024 | 35.3% | +138.0 |
| Q2 FY2024 | Jun 30, 2024 | -4.2% | +5.0 |
| Q1 FY2024 | Mar 31, 2024 | 2.7% | −5.5 |
| Q4 FY2023 | Dec 31, 2023 | -13.6% | −8.1 |
| Q3 FY2023 | Sep 30, 2023 | -102.6% | −96.3 |
| Q2 FY2023 | Jun 30, 2023 | -9.2% | −8.3 |
| Q1 FY2023 | Mar 31, 2023 | 8.2% | +4.0 |
| Q4 FY2022 | Dec 31, 2022 | -5.5% | +4.0 |
| Q3 FY2022 | Sep 30, 2022 | -6.3% | +3.2 |
| Q2 FY2022 | Jun 30, 2022 | -0.9% | +15.3 |
| Q1 FY2022 | Mar 31, 2022 | 4.2% | +9.3 |
| Q4 FY2021 | Dec 31, 2021 | -9.4% | +18.9 |
| Q3 FY2021 | Sep 30, 2021 | -9.5% | +5.6 |
| Q2 FY2021 | Jun 30, 2021 | -16.1% | −7.1 |
| Q1 FY2021 | Mar 31, 2021 | -5.1% | +2.3 |
| Q4 FY2020 | Dec 31, 2020 | -28.3% | −27.1 |
| Q3 FY2020 | Sep 30, 2020 | -15.2% | −16.5 |
| Q2 FY2020 | Jun 30, 2020 | -9.0% | −13.6 |
| Q1 FY2020 | Mar 31, 2020 | -7.4% | −11.8 |
| Q4 FY2019 | Dec 31, 2019 | -1.2% | −3.3 |
| Q3 FY2019 | Sep 30, 2019 | 1.3% | −6.6 |
| Q2 FY2019 | Jun 30, 2019 | 4.6% | +12.7 |
| Q1 FY2019 | Mar 31, 2019 | 4.3% | −5.6 |
| Q4 FY2018 | Dec 31, 2018 | 2.1% | +23.5 |
| Q3 FY2018 | Sep 30, 2018 | 7.9% | +10.9 |
| Q2 FY2018 | Jun 30, 2018 | -8.2% | −4.0 |
| Q1 FY2018 | Mar 31, 2018 | 9.9% | +23.8 |
| Q4 FY2017 | Dec 31, 2017 | -21.4% | – |
| Q3 FY2017 | Sep 30, 2017 | -3.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -4.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -13.9% | – |
See a number that looks wrong?